Figure 4

![Figure 4: Clinical trial summary data for EGb 761 in mild cognitive impairment and early dementia, including patient populations and treatment durations.]()

> Source: Carlo Tomino et al. "Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®." *Pharmaceuticals (Basel, Switzerland)*, 2021. PMID: [33915701](https://pubmed.ncbi.nlm.nih.gov/33915701/)

<figure>
  <img src="" alt="Clinical trial summary data for EGb 761 in mild cognitive impairment and early dementia, including patient populations and treatment durations." />
  <figcaption>Figure 4. Clinical trial summary data for EGb 761 in mild cognitive impairment and early dementia, including patient populations and treatment durations.<br>  Source: Carlo Tomino et al. "Mild Cognitive Impairment and Mild Dementia: The Role of Ginkgo biloba (EGb 761®." <em>Pharmaceuticals (Basel, Switzerland)</em>, 2021. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/33915701/">33915701</a></figcaption>
</figure>